EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Endocarditis and other indications for open-heart surgery after a transcatheter aortic valve implant

Torbjörn Ivert iD, Aninda Omar, Andreas Rück, Magnus Dalén iD

Interdisciplinary CardioVascular and Thoracic Surgery · 2025

DOI: 10.1093/icvts/ivaf173 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2025. Verfasst von Torbjörn Ivert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Karolinska University Hospital and Molecular Medicine and Surgery, Karolinska Institutet, 17177 Stockholm, Swed…. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Endocarditis, Prosthesis-Related Infections, Postoperative Complications. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fredrik Lundberg and Schörling Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective observational single-centre analysis included 31 patients who underwent transcatheter aortic valve implantation (TAVI) between 2016 and 2024 and subsequent open-heart surgery between 2019 and 2024. They were admitted from infectious disease departments or cardiology clinics and accounted for 0.7% of heart operations performed in 2024. The incidence of definite endocarditis was 0.5% (17/3226) of all TAVI procedures performed during this period. Of the 17 patients, 9 (53%) with definite endocarditis underwent aortic valve replacement, with 1 early death (11%) from bowel ischaemia and liver failure. The 2-year postoperative survival for definite endocarditis was 76%. Open-heart surgery was contraindicated in all 8 patients with definite endocarditis due to severe comorbidities and frailty. These patients died within 2 years of the infection or due to heart failure. Furthermore, 10 patients classified as having endocarditis after TAVI were medically treated and had a 2-year survival rate of 72%. The survival rate was 87% at 2 years after open-heart surgery for non-infectious indications performed up to 5 years after TAVI in 22 patients. In conclusion, heart surgery can be curative in selected patients with definite endocarditis after TAVI and lifesaving after rare TAVI complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementEndocarditisProsthesis-Related InfectionsPostoperative ComplicationsCardiac Surgical ProceduresHumansMaleFemaleRetrospective StudiesAged, 80 and overAgedRisk FactorsTreatment OutcomeTime FactorsIncidence

Stichwörter der Autor:innen

TAVIendocarditisvalve dysfunction

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Karolinska University Hospital and Molecular Medicine and Surgery, Karolinska Institutet, 17177 Stockholm, Sweden.
  • Division of Cardiology, Department of Medicine, Karolinska Institutet, 17177 Stockholm, Sweden.

ORCID-Profile: Torbjörn Ivert, Magnus Dalén

Förderung

  • Fredrik Lundberg and Schörling Foundation

Zitieren

APA

Ivert, T., Omar, A., Rück, A., & Dalén, M. (2025). Endocarditis and other indications for open-heart surgery after a transcatheter aortic valve implant. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivaf173

Vancouver

Ivert T, Omar A, Rück A, Dalén M. Endocarditis and other indications for open-heart surgery after a transcatheter aortic valve implant. Interdisciplinary CardioVascular and Thoracic Surgery. 2025. doi:10.1093/icvts/ivaf173

BibTeX
@article{Ivert2025,
  author = {Ivert, Torbjörn and Omar, Aninda and Rück, Andreas and Dalén, Magnus},
  title = {Endocarditis and other indications for open-heart surgery after a transcatheter aortic valve implant},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2025},
  doi = {10.1093/icvts/ivaf173}
}
Kostenlos starten →